Mel-Mont Medical Honored with Best Innovative Technology Award for HPV mRNA-Based Triage
Mel-Mont Medical received the Best Innovative Technology Award at the 2026 ASCCP Scientific Meeting for its Proofer 7 HPV mRNA E6/E7 Biomarker Test, part of the Mía Comprehensive Cervical Cancer Test. This recognition highlights the need for patient-centered cervical cancer screening solutions, particularly for HPV-positive patients. The test aims to improve accessibility and provide more specific risk assessments following a positive HPV result, aligning with recent federal guidance on patient-collected HPV testing.
Recognition highlights growing momentum toward more accessible, patient-centered screening and type specific risk assessment after a positive HPV result DORAL, Fla., May 5, 2026 /PRNewswire/ — Mel-Mont Medical, a women’s health diagnostics company advancing accessible cervical cancer…